← Back to headlines
Bristol Myers Wins FDA Priority Review for Multiple Myeloma Therapy
Bristol Myers has received FDA priority review for its multiple myeloma therapy, indicating a potential acceleration in the drug's approval process.
17 Feb, 19:12 — 17 Feb, 19:12
Sources
Showing 1 of 1 sources
Related Stories
Philippines Grapples with Persistent Unsafe Abortions Despite Ban
just now
Moldovan Parliament Debates Tax, Environment, and Drug Trafficking Reforms
12m ago
North Macedonia Introduces Second Medical Opinion Service
13m ago
Thursday's Top News Briefing Highlights Fuel Protests, Maternity Hospital Incidents, and Artemis II
14m ago